Grants to Advance Research and Patient Support
Kyowa Kirin funds independent research and education projects to advance diagnosis, management, and care for CTCL, focusing on Mycosis Fungoides and Sézary syndrome and addressing disparities in rare hematologic cancers.
Funder: Kyowa Kirin
Due Dates: July 31, 2026: Full application deadline for CME Grant for Education on Cutaneous T‑Cell Lymphoma (CTCL) | December 10, 2020: Patient Education Grants to Address CTCL Disparities | August 20, 2020: Patient Education Grant Program to Address Disparities for African American Patients with CTCL
Funding Amounts: CME CTCL Education: $5,000–$100,000 per project; Patient Education Disparities: up to $35,000 per project; total program funds up to $100,000.
Summary: Supports independent research, medical education, and community initiatives focused on rare diseases—especially hematologic cancers and CTCL—improving patient outcomes and addressing health disparities.
Key Information: Current open RFP focuses on CME for CTCL (MF and SS subtypes); previous rounds targeted patient education and disparities.
Description
Kyowa Kirin offers a suite of grants to advance research, medical education, and patient/community support projects in rare diseases, with a significant focus on hematologic cancers such as Cutaneous T-Cell Lymphoma (CTCL). The current open opportunity is for independent Continuing Medical Education (CME) initiatives addressing unmet needs in the diagnosis and management of CTCL subtypes, Mycosis Fungoides (MF) and Sézary syndrome (SS). Past grant rounds have specifically targeted patient education and health disparities, particularly among African American patients with CTCL. Supported projects may include educational programs, data collection, disease registries, investigator-initiated studies, and advocacy or outreach efforts that align with Kyowa Kirin’s therapeutic priorities.
